Acquirers Acquire Up to 28.90 Lakh Equity Shares of Rekvina Laboratories in Open Offer

Acquirers Acquire Up to 28.90 Lakh Equity Shares of Rekvina Laboratories in Open Offer​

The acquisition of equity shares of Rekvina Laboratories Limited has been underway through an Open Offer conducted by Surbhit Mukesh Shah, Amit Mukesh Shah, and Dhruvalkumar Patel. The offer sought the purchase of up to 28,90,100 fully paid-up equity shares of Rekvina Laboratories Limited (the 'Target Company').

The Acquirers are Surbhit Mukesh Shah (Acquirer 1), Amit Mukesh Shah (Acquirer 2), and Dhruvalkumar Patel (Acquirer 3). The offer details reflect the acquisition of these shares from public shareholders.

Key aspects of the open offer include:

• Target: Rekvina Laboratories Limited
• Shares Offered: Up to 28,90,100 Equity Shares
• Face Value: ? 5/- (Rupees Five only) per share
• Representation: The shares represent 26% of the expanded share capital.

Vivro Financial Services Private Limited served as the Manager to the Offer. The offer opened on July 1, 2026, and was scheduled to close on July 14, 2026.

Acquisition Details and Shareholding​

The transaction involves both a preferential issue for consideration by way of swap of shares and the acquisition through the open market. The underlying transaction contemplated under SEPA is set to be consummated following approval for the proposed Preferential Issue for consideration by way of swap of shares.

In one segment of the transaction, involving Surbhit Mukesh Shah, 3,33,845 Equity Shares were issued at ? 10/- per share of the Target Company, generating a total consideration of 1,33,537. Similarly, 3,33,843 shares belonging to Krima Surbhit Shah were acquired against a total consideration of 1,33,537.

The table below provides details on the equity shares issuance and acquisition by the Acquirers:


The Acquirer structure suggests that Acquirer-1 and Acquirer-2 are existing members of the Promoter and Promoter Group of the Target Company. Acquirer-3 is classified as a joint Promoter along with the existing members of the Promoter and Promoter group. Post completion of the Open Offer and subsequent acquisition of Subscription Shares under the Underlying Transaction, the shareholding of the Acquirers, alongside other members of the Promoter and Promoter group, is estimated to be 85,59,096 Equity Shares, representing 77.00% of the Expanded Share Capital of the Target Company.

The acquisition details presented in a separate table detail the overall scale of the offer:

Financial Highlights: Aarnav Fashions Limited​

In a separate business update provided by Aarnav Fashions Limited for the quarter ended on June 30, 2026 (amounts in Lakhs, except EPS), the company reported its un-audited financial results.

The total income stands at 46308.03. The cost of materials consumed was 130.41. Total expenses amounted to 44994.92, resulting in a Profit from ordinary activities before exceptional items (3-4) of 225.60.

Key financial metrics for the period are:

Stock Price Movement​

Rekvina Laboratories Ltd settled Friday at ₹25.00, dipping 0.99% in the closing trade. The shares traded completely flat throughout the session, maintaining a locked price range of ₹25.00.